Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
radiopharmaceuticals
Pharma
Novartis builds momentum with new drug launches
Novartis CEO Vas Narasimhan acknowledged that the company could have made its recent $23 billion U.S. investment plan sooner.
Angus Liu
Apr 29, 2025 10:52am
Novartis unveils $23B investment to beef up US manufacturing, R&D
Apr 10, 2025 3:18pm
CDMO PharmaLogic takes majority stake in radiopharma pro Agilera
Apr 9, 2025 3:00pm
Novartis' Pluvicto wins key FDA nod toward $5B-plus sales target
Mar 28, 2025 3:02pm
Lantheus snaps up radiopharma CDMO Evergreen for $250M+
Jan 28, 2025 10:08am
Where is the industry going with its rush to radiopharma?
Jan 10, 2025 3:00am
